Clara Ruíz-Ponte - Concepedia

Author

Clara Ruíz-Ponte

Fundación Pública Galega de Medicina Xenómica ORCID

Also Known As

C RUIZPONTE, C Ruiz-Ponte, C Ruiz‐Ponte, C Ruíz-Ponte, C Ruíz‐Ponte, C. RUIZ‐PONTE, C. Ruiz-Ponte, C. Ruiz‐Ponte, Clara Ruiz-Ponte, Clara Ruiz‐Ponte

124

Publications

4.8K

Citations

H-Index

Concepts

All Affiliations

Fundación Pública Galega de Medicina Xenómica Universidade de Santiago de Compostela Universitat de Barcelona Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas Consorci Institut D'Investigacions Biomediques August Pi I Sunyer

About

Clara Ruíz-Ponte is an author at Fundación Pública Galega de Medicina Xenómica specializing in medicine, pathology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	23	1.9K
2	Public Health	7	7	400
3	Biostatistics	2	2	44
4	Health Sciences	1	1	166
5	Allergy	1	1	32

Clara Ruíz-Ponte

Publications

3.5K

Citations

H-Index

Page 1

	Year	Citations
A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3 Ian PM Tomlinson, Emily L. Webb, Luis G. Carvajal‐Carmona, Nature Genetics Cancer SusceptibilityGenome-wide Association StudyChromosomes 10P14MedicineGenetics	2008	561
Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia risk Dalemari Crowther-Swanepoel, Peter Broderick, Maria Chiara Di Bernardo, Nature Genetics Hematological MalignancyAllelic VariantOncologyMedicineGenetics	2010	224
Risk of Cancer in Cases of Suspected Lynch Syndrome Without Germline Mutation María Rodríguez–Soler, Lucía Pérez–Carbonell, Carla Guarinós, Gastroenterology EpidemiologySomatic VariantCancer PathologyCancer RiskGenetic Disorder	2013	215
Comparison between universal molecular screening for Lynch syndrome and revised Bethesda guidelines in a large population-based cohort of patients with colorectal cancer Lucía Pérez–Carbonell, Clara Ruíz-Ponte, Carla Guarinós, Gut	2011	187
Mutational Signature Analysis Reveals NTHL1 Deficiency to Cause a Multi-tumor Phenotype Judith E. Grolleman, Richarda M. de Voer, Fadwa A. Elsayed, Cancer Cell Tumor BiologyMulti-tumor PhenotypeSomatic VariantTumor HeterogeneityMedicine	2019	166
Cumulative impact of common genetic variants and other risk factors on colorectal cancer risk in 42 103 individuals Malcolm G. Dunlop, Albert Tenesa, Susan M. Farrington, Gut	2012	137
A candidate gene study of capecitabine-related toxicity in colorectal cancer identifies new toxicity variants at <i>DPYD</i> and a putative role for <i>ENOSF1</i> rather than <i>TYMS</i> Dan Rosmarin, Claire Palles, Alistair T. Pagnamenta, Gut	2014	100
Diagnosis of Constitutional Mismatch Repair-Deficiency Syndrome Based on Microsatellite Instability and Lymphocyte Tolerance to Methylating Agents Sahra Bodo, Chrystelle Colas, Olivier Buhard, Gastroenterology Primary ImmunodeficiencyMethylating AgentsGenetic TestingLymphocyte ToleranceAutoimmune Disease	2015	96
Patterns of genetic differentiation and the footprints of historical migrations in the Iberian Peninsula Clare Bycroft, Ceres Fernández–Rozadilla, Clara Ruíz-Ponte, Nature Communications	2019	92
Whole-exome sequencing identifies rare pathogenic variants in new predisposition genes for familial colorectal cancer Clara Esteban-Jurado, María Vila-Casadesús, Pilar Garré, Genetics in Medicine	2014	90

Page 1